Recombinant Human APOC4 Protein，His

APOC4, or Apolipoprotein C4, is a member of the apolipoprotein family, which plays a crucial role in lipid metabolism and cardiovascular health. Recent research has increasingly focused on its involvement in various metabolic disorders, including obesity and type 2 diabetes. APOC4 is known to modulate lipid transport and interaction with other apolipoproteins, thereby influencing triglyceride levels and overall lipid profiles in the bloodstream. Despite its pivotal role, the exact mechanisms underlying APOC4's function and its potential as a therapeutic target remain inadequately understood. Studies have indicated that alterations in APOC4 expression can lead to dyslipidemia, which is a significant risk factor for cardiovascular diseases. Therefore, the recombination and expression of APOC4 proteins for functional studies have garnered significant interest. By utilizing recombinant DNA technology, researchers aim to produce large quantities of APOC4 for in-depth biochemical assays and structural analysis. This research not only enhances our understanding of APOC4's role in lipid metabolism but also paves the way for developing targeted therapies for metabolic diseases linked to dyslipidemia. Understanding APOC4's structure and function could eventually lead to novel interventions for managing lipid-related disorders and reducing cardiovascular risks associated with aberrant lipid profiles. The ongoing exploration of APOC4, particularly through the lens of recombinant protein technology, represents a promising frontier in cardiovascular and metabolic health research.